OYST

Oyster Point Pharma (OYST)

Oyster Point Pharma Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OYST

1 2 3 4 5 6 7 8 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
14/02/2023	22h34	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OYST	Oyster Point Pharma Inc
14/02/2023	16h06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OYST	Oyster Point Pharma Inc
13/01/2023	23h11	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:OYST	Oyster Point Pharma Inc
13/01/2023	23h06	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:OYST	Oyster Point Pharma Inc
06/01/2023	12h04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OYST	Oyster Point Pharma Inc
05/01/2023	22h33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:OYST	Oyster Point Pharma Inc
05/01/2023	22h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
05/01/2023	00h12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
04/01/2023	23h11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
04/01/2023	23h10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
04/01/2023	23h09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
04/01/2023	23h05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
04/01/2023	23h03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
04/01/2023	23h03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	15h53	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	15h26	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	15h19	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	15h07	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OYST	Oyster Point Pharma Inc
23/12/2022	12h31	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OYST	Oyster Point Pharma Inc
22/12/2022	23h16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:OYST	Oyster Point Pharma Inc
21/12/2022	12h04	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:OYST	Oyster Point Pharma Inc
09/12/2022	13h01	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OYST	Oyster Point Pharma Inc
09/12/2022	13h01	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OYST	Oyster Point Pharma Inc
06/12/2022	14h51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
05/12/2022	23h37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
02/12/2022	14h00	GlobeNewswire Inc.	Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OYST	Oyster Point Pharma Inc
01/12/2022	13h39	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:OYST	Oyster Point Pharma Inc
01/12/2022	12h12	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:OYST	Oyster Point Pharma Inc
16/11/2022	22h25	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:OYST	Oyster Point Pharma Inc
14/11/2022	14h10	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:OYST	Oyster Point Pharma Inc